WO2023104846 - IMPROVED PROTEIN PRODUCTION IN RECOMBINANT BACTERIA
National phase entry:
Publication Number
WO/2023/104846
Publication Date
15.06.2023
International Application No.
PCT/EP2022/084700
International Filing Date
07.12.2022
Title **
[English]
IMPROVED PROTEIN PRODUCTION IN RECOMBINANT BACTERIA
[French]
PRODUCTION AMÉLIORÉE DE PROTÉINES DANS DES BACTÉRIES RECOMBINÉES
Applicants **
NOVOZYMES A/S
Inventors
NIELSEN, Allan, Kent
ANDERSEN, Rasmus, Lund
APPEL, Karen, fuglede
VUKMAN, Anna, Lund
Priority Data
PA202101180
10.12.2021
DK
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2301 | |
| EPO | Filing, Examination, Granting | 9447 | |
| Japan | Filing, Examination, Granting | 2215 | |
| South Korea | Filing, Examination, Granting | 2179 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
22,082
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to mutated bacterial host cells with increased SpoVG polypeptide expression, and nucleic acid constructs and expression vectors encoding SpoVG polypeptides. The invention also relates to methods of producing a protein of interest using the mutated bacterial host cells.[French]
La présente invention concerne des cellules hôtes bactériennes mutées présentant une expression accrue du polypeptide SpoVG, ainsi que des constructions d'acides nucléiques et des vecteurs d'expression codant pour des polypeptides SpoVG. L'invention concerne également des procédés de production d'une protéine d'intérêt à l'aide des cellules hôtes bactériennes mutées.